Summary
- Current Price
- As of today, ATXI price is $0.18, down -32.66% in the most recent trading session on
- Current Price All-Time High
- ATXI price is currently -100.00% below its historical high of $13,882.27 set on
- Market Cap
- ATXI current market cap is $573K, down -72.82% year-over-year
- PE Ratio
- ATXI PE ratio is unknown
- Revenue
- ATXI current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ATXI has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Avenue Therapeutics, Inc. |
| Ticker | NASDAQ: ATXI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | avenuetx.com |
| Employees | 2 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.18 | ||
| Price, 1D Change | -32.66% | |
| $573K | ||
| - | ||
| - | ||
| -0.18 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$9.00 | ||
| EPS, 1Y Change | +87.76% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:75 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$9.00 | ||
| EPS Estimate | N/A | -$1.96 |
| EPS Est. Change | N/A | +78.21% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.18 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.97 | -$73.48 | -7,475.31% | |
| - | -$9.00 | - | |
| -$1.96 | N/A | +78.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -82.00% | ||
| -99.77% | ||
| -72.82% | ||
| -90.22% | ||
| 0.00% | ||
| 0.00% | ||
| +87.76% | ||
| +96.36% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.18 | ||
| $0.53 | ||
| SMA 200 vs Price | +192.00% | |
| $0.41 | ||
| SMA 50 vs Price | +127.44% | |
| -0.18 | ||
| $0.04 | ||
| 49.82 | ||
| 499.04% | ||
| 216.66% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$9.00 | ||
| $0.00 | ||
| - | ||
| -$11.28M | ||
| - | ||
| -$11.70M | ||
| - | ||
| -$11.28M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.27 | ||
| 3.27 | ||
| - | ||
| - | ||
| -66.43 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.41 | ||
| 0.16 | ||
| 0.80 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $2.80M | ||
| $2.59M | ||
| $2.67M | ||
| $2.67M | ||
| $816.00K | ||
| $816.00K | ||
| $0.00 | ||
| $0.00 | ||
| $155.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $11.65M | ||
| $11.28M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$9.03M | ||
| $0.00 | ||
| $9.84M | ||
| $0.00 | ||
| -$9.03M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | ||
| Aegis Capital | ||
| HC Wainwright & Co. | ||
| Oppenheimer | ||
| H.C. Wainwright |
Analyst sentiment
Institutional ownership
Screeners with ATXI
FAQ
What is the ticker symbol for Avenue Therapeutics, Inc.?
The ticker symbol for Avenue Therapeutics, Inc. is NASDAQ:ATXI
Does Avenue Therapeutics, Inc. pay dividends?
No, Avenue Therapeutics, Inc. does not pay dividends
What sector is Avenue Therapeutics, Inc. in?
Avenue Therapeutics, Inc. is in the Healthcare sector
What industry is Avenue Therapeutics, Inc. in?
Avenue Therapeutics, Inc. is in the Biotechnology industry
What country is Avenue Therapeutics, Inc. based in?
Avenue Therapeutics, Inc. is headquartered in United States
When did Avenue Therapeutics, Inc. go public?
Avenue Therapeutics, Inc. initial public offering (IPO) was on June 27, 2017
Is Avenue Therapeutics, Inc. in the S&P 500?
No, Avenue Therapeutics, Inc. is not included in the S&P 500 index
Is Avenue Therapeutics, Inc. in the NASDAQ 100?
No, Avenue Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Avenue Therapeutics, Inc. in the Dow Jones?
No, Avenue Therapeutics, Inc. is not included in the Dow Jones index
When was Avenue Therapeutics, Inc. last earnings report?
Avenue Therapeutics, Inc.'s most recent earnings report was on August 14, 2018
When does Avenue Therapeutics, Inc. report earnings?
The date for Avenue Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ATXI Official Website www.avenuetx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1644963/000143774925010196/0001437749-25-010196-index.htm
- ATXI Profile on Yahoo Finance finance.yahoo.com/quote/ATXI
- ATXI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atxi